What NextGen Ventures does

NextGen Ventures (NXG) is a Netherlands-based venture capital firm founded in 2013 by Edward van der Meer, Matthijs Blokhuis, and Peter Haasjes, specializing in early-stage digital health and medtech startups across the Netherlands, Germany, and Belgium. The firm invests at the seed and early stages, typically committing up to €2M initially per company with follow-on capacity, and targets ventures addressing unmet medical needs aligned with the Quadruple Aim framework. Its geographic scope spans the Benelux and DACH regions, with explicit exclusion of biotech and pharmaceuticals.

The firm operates three successive funds (NXG1, NXG2, NXG3), with NXG3 holding a €28.5 million first close in January 2026 and capacity to support up to 15 portfolio companies. Since inception it has backed more than 20 portfolio companies, including AMT Medical (heart bypass), Plasmacure (cold plasma wound care), Momo Medical (smart sensor mattresses in 250+ nursing homes), Attendi (voice-driven clinical reporting used by 180+ care providers), ShanX Medtech (rapid infection diagnostics), STENTiT (biodegradable stents), Sirius Medical (surgical navigation), and Vivalyx (organ preservation). Cornerstone limited partners Noaber Foundation and Stichting Triade have anchored the firm since founding, and recent syndicates include PGGM, Invest-NL, EIC, Borski Fund, and US-based Venture Medical.

Revenue mechanics follow the standard VC model of management fees on committed capital plus carried interest on exits; the firm does not disclose revenue. Distribution occurs through direct outreach, network referrals, a "partner up" collaboration page on its website, and participation in industry events. The investment team of approximately seven professionals plus three venture partners and an advisory board brings prior operating and consulting experience from Philips, Bain & Company, Polyganics, VitalHealth Software, Accenture, and Royal Haskoning, giving the firm a hands-on support posture beyond capital provision.

Name

NextGen Ventures

Legal name

NextGen Ventures Management B.V.

Website

https://nextgenventures.nl

Company type

Private

Founded year

2013

Operating status

Operating

Headcount range

1–10 employees

Short description

NextGen Ventures is a Netherlands-based venture capital firm investing in early-stage digital health and medtech startups across the Netherlands, Germany, and Belgium, having backed over 20 portfolio companies through three successive funds since 2013.

Ownership category

akta.pro rank

Product category

Healthcare Venture Capital

NAICS

Other Investment Pools and Funds (5259), Portfolio Management and Investment Advice (523940)

SIC

Investment Advice (6282)

akta.pro primary industry

Sector-Focused Venture Capital (Vertical Specialists) (FSANAAAD)

akta.pro secondary industry

SDG / Thematic Sustainable Investment Funds (FSANAJAN)

Keywords

• Healthcare venture capital
• Medtech seed investing
• Digital health startups
• Early-stage healthcare financing
• Venture capital funds

Headquarters

HQ city

Lunteren

HQ country

Netherlands

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D

Revenue model

1. Venture Capital Returns: NextGen Ventures generates returns through equity investments in early-stage healthcare startups. The firm earns returns via carried interest and management fees from its investment funds (NXG1, NXG2, and NXG3). Portfolio companies receive venture capital financing in exchange for equity stakes.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

NextGen Ventures is a venture capital firm that invests seed and early-stage capital (initial investments up to €2M) in digital health and medtech startups based in the Netherlands, Germany, and Belgium. The firm provides equity financing from dedicated funds (NXG1, NXG2, NXG3) along with hands-on strategic support, operational guidance, and access to an extensive healthcare network to help portfolio companies navigate regulatory, reimbursement, and commercialization challenges.

Product overview

NextGen Ventures (NXG) is a venture capital firm that provides early-stage investment and strategic support to medtech and digital health startups in the Netherlands, Germany, and Belgium. It does not develop or sell its own product or technology — its offering is venture capital funding, operational expertise, and network access for portfolio companies. As such, it has no distinct product, module, or named service offering of its own.

Differentiator

Problem solved

Functional benefit

Quantifiable outcome

• Over 20 portfolio companies supported since 2013
• +1 more outcomes

Named customers16 records

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators4 records

Recent moves7 records

Expansion highlights5 records

Regional players

• InnovationQuarter: Dutch regional development agency investing in early-stage innovation including healthcare ventures. Regional peer operating in the Netherlands, frequently co-invests with NextGen Ventures (e.g., Momo Medical round).
• Oost NL: Dutch regional development agency for Eastern Netherlands, active co-investor in healthcare ventures alongside NextGen Ventures (AMT Medical, Plasmacure). Regional peer and frequent syndicate partner rather than direct competitor.

Direct peers

• EQT Life Sciences (formerly LSP): European healthcare specialist investor with strong Dutch roots, investing across life sciences and healthtech. Direct peer in healthcare specialization; substantially larger in AUM and broader in stage range.
• BioGeneration Ventures (BGV): Dutch early-stage venture capital firm backing biotech and medtech startups across the Benelux region. Direct peer given Dutch base, early-stage healthcare focus, and similar check sizes, though with stronger biotech orientation.
• Forbion: Leading Dutch life sciences venture capital firm focused on biopharma and medtech, managing multiple funds from the Netherlands. Direct peer due to shared Dutch base, healthcare specialization, and similar fund structure; larger in AUM but operates in overlapping subsectors.
• Earlybird Health: German-based early-stage venture capital firm dedicated to healthtech and digital health investments across Europe. Direct peer given shared DACH geographic focus and digital health/medtech early-stage mandate.
• Kurma Partners: European healthcare specialist VC firm based in Paris, active across digital health and therapeutics. Direct peer given European healthcare focus and early-to-growth stage orientation.
• Gilde Healthcare: Dutch-based sector-focused healthcare venture and growth capital firm investing in medtech, digital health, and therapeutics across Europe and the US. Closest direct peer to NextGen Ventures given shared geography, healthcare-only focus, and similar stage orientation.
• Seventure Partners: Paris-based European venture capital firm with a dedicated Health for Life strategy covering digital health, medtech, and microbiome. Direct peer in European healthcare specialization and early-stage focus.

Emerging players

• Asabys Partners: Barcelona-based venture capital firm investing in early-stage healthtech and digital health across Europe. Emerging peer with similar early-stage healthcare focus but smaller fund size and different geographic base.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks4 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/nextgen-ventures

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments20 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about NextGen Ventures